Sharon, CT, United States of America

John P Devlin

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Poughkeepsie, NY (US) (1986 - 1988)
  • Sharon, CT (US) (1986 - 1996)

Company Filing History:


Years Active: 1986-1996

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: John P. Devlin: A Pioneer in Pharmaceutical Innovations

Introduction

John P. Devlin, based in Sharon, CT, has made significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, he has established himself as a key figure in developing novel compounds that address various medical conditions. His work showcases the intersection of creativity and scientific rigor in the realm of innovation.

Latest Patents

Among John P. Devlin's latest patents are the alkylarylketo acids, which include novel alkylarylketocarboxylic acids and 5-substituted tetrazoles. These compounds are represented by specific structural formulas, where Z is aryl or an alkyl of a described structure, and W is either a carboxyl moiety or a tetrazole moiety bound to Z at the 5-position of the tetrazole. Another noteworthy patent involves anti-inflammatory thienylbenzylamine compounds, which demonstrates the potential of these compounds for the treatment of inflammation.

Career Highlights

John has worked with leading companies in the pharmaceutical industry, notably Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim GmbH. His career trajectory is marked by his dedication to research and the development of innovative therapeutic solutions that can greatly enhance patient care.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues such as Karl D. Hargrave and Edward L. Barsumian. These collaborative efforts underscore the importance of teamwork in addressing complex pharmaceutical challenges and advancing the field through shared expertise and knowledge.

Conclusion

John P. Devlin's contributions to the pharmaceutical industry exemplify the spirit of innovation and dedication to improving healthcare outcomes. His patents reflect a commitment to research and development that will continue to shape the landscape of medical treatments for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…